This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA

Dr Robert Salmon
Head of Bioprocess at Constructive Bio
Speaker

Profile

Rob is Head of Bioprocess at Constructive Bio, where he leads the development and scale-up of novel microbial strains for the production of peptides and proteins containing non-canonical amino acids and their subsequent downstream processing.

Rob has extensive experience across the full bioprocess development workflow, gained through roles at multiple biotechnology companies in the UK. Most recently, he led the scale-up and manufacture of Johnson Matthey’s enzyme portfolio, delivering processes from development through to production. He holds a PhD in microbial physiology and protein biochemistry from the University of Sheffield.

Agenda Sessions

  • Biomanufacturing Therapeutic Peptides at Scale with an Expanded Genetic Code

    11:40am